The same results were observed for the following subgroup analyses: by age group, tumour stage and MYCN status for neuroblastoma; with stratification by gender for medulloblastoma; by considering laterality for retinoblastoma (Table 4). The gene discussed is MYCN; the disease is medulloblastoma.